Hiroki Hayashi

1.0k total citations
71 papers, 494 citations indexed

About

Hiroki Hayashi is a scholar working on Nephrology, Rheumatology and Molecular Biology. According to data from OpenAlex, Hiroki Hayashi has authored 71 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Nephrology, 16 papers in Rheumatology and 12 papers in Molecular Biology. Recurrent topics in Hiroki Hayashi's work include Dialysis and Renal Disease Management (16 papers), Chronic Kidney Disease and Diabetes (12 papers) and Renal Diseases and Glomerulopathies (12 papers). Hiroki Hayashi is often cited by papers focused on Dialysis and Renal Disease Management (16 papers), Chronic Kidney Disease and Diabetes (12 papers) and Renal Diseases and Glomerulopathies (12 papers). Hiroki Hayashi collaborates with scholars based in Japan, United States and United Kingdom. Hiroki Hayashi's co-authors include Yukio Yuzawa, Midori Hasegawa, Kazuo Takahashi, Daijo Inaguma, Naotake Tsuboi, Shoichi Maruyama, Seiichi Matsuo, Eri Ito, Takahiro Inakuma and Shinichi Kakumu and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroki Hayashi

67 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Hayashi Japan 12 196 117 110 77 70 71 494
Francesca Tinti Italy 13 135 0.7× 105 0.9× 96 0.9× 150 1.9× 48 0.7× 49 662
P Berthoux France 13 180 0.9× 27 0.2× 91 0.8× 98 1.3× 65 0.9× 26 510
Jyh-Chang Hwang Taiwan 12 185 0.9× 27 0.2× 62 0.6× 48 0.6× 57 0.8× 27 382
Leena Ong-Ajyooth Thailand 10 145 0.7× 78 0.7× 50 0.5× 34 0.4× 33 0.5× 32 337
Yufeng Qing China 14 311 1.6× 138 1.2× 74 0.7× 31 0.4× 17 0.2× 44 567
Jan Bruensing Germany 10 38 0.2× 61 0.5× 146 1.3× 50 0.6× 67 1.0× 14 395
Saima Chohan United States 11 224 1.1× 200 1.7× 26 0.2× 24 0.3× 34 0.5× 19 432
Pedram Ahmadpoor Iran 16 101 0.5× 35 0.3× 134 1.2× 20 0.3× 44 0.6× 57 632
Chiara Cantarelli Italy 14 206 1.1× 23 0.2× 77 0.7× 22 0.3× 49 0.7× 31 544
Calogero Lino Cirami Italy 12 133 0.7× 55 0.5× 28 0.3× 15 0.2× 59 0.8× 37 499

Countries citing papers authored by Hiroki Hayashi

Since Specialization
Citations

This map shows the geographic impact of Hiroki Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Hayashi more than expected).

Fields of papers citing papers by Hiroki Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Hayashi. The network helps show where Hiroki Hayashi may publish in the future.

Co-authorship network of co-authors of Hiroki Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Hayashi. A scholar is included among the top collaborators of Hiroki Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Hayashi. Hiroki Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isaka, Yoshitaka, Yusuke Sakaguchi, Maki Shinzawa, et al.. (2025). Rituximab for Relapsing Nephrotic Syndrome in Adults. JAMA. 334(22). 2011–2011.
2.
Ito, Yoshimasa, Kazuo Takahashi, Hiroki Hayashi, et al.. (2025). Investigation of the Impact of Tryptophan‐Metabolizing Enzymes and Kynurenic Acid on Antibody‐Mediated Glomerulonephritis. The FASEB Journal. 39(18). e71076–e71076.
3.
Hayashi, Hiroki, Soshiro Ogata, Shigeo Hara, et al.. (2024). Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study. Clinical and Experimental Nephrology. 29(3). 259–268.
4.
5.
Hayashi, Hiroki, Soshiro Ogata, Kazuo Takahashi, et al.. (2023). Tolvaptan’s Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. American Journal of Nephrology. 54(7-8). 319–328. 2 indexed citations
6.
7.
Yamaguchi, Hisateru, Soshiro Ogata, Sharon Natasha Cox, et al.. (2022). Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy. iScience. 25(11). 105223–105223. 7 indexed citations
8.
Ogata, Soshiro, Kazuo Takahashi, Naotake Tsuboi, et al.. (2020). Long-term changes in renal function after treatment initiation and the importance of early diagnosis in maintaining renal function among IgG4-related tubulointerstitial nephritis patients in Japan. Arthritis Research & Therapy. 22(1). 261–261. 5 indexed citations
9.
Ogata, Soshiro, Shigeo Hara, Kazuo Takahashi, et al.. (2020). Comparison of the 2018 and 2003 International Society of Nephrology/Renal Pathology Society classification in terms of renal prognosis in patients of lupus nephritis: a retrospective cohort study. Arthritis Research & Therapy. 22(1). 260–260. 17 indexed citations
10.
Katsuno, Takayuki, Hiroki Hayashi, Sawako Kato, et al.. (2018). Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease. American Journal of Nephrology. 49(1). 54–63. 4 indexed citations
11.
Inaguma, Daijo, Eri Ito, Kazuo Takahashi, et al.. (2018). Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan. Clinical and Experimental Nephrology. 22(6). 1360–1370. 6 indexed citations
12.
13.
Hayashi, Hisao, Yasuaki Tatsumi, Hiroki Hayashi, et al.. (2015). Acute Hepatic Phenotype of Wilson Disease: Clinical Features of Acute Episodes and Chronic Lesions Remaining in Survivors. Journal of Clinical and Translational Hepatology. 3(4). 239–245. 2 indexed citations
14.
Hasegawa, Midori, Kyoko Hattori, Satoshi Sugiyama, et al.. (2015). A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients. Modern Rheumatology. 26(1). 110–114. 7 indexed citations
15.
Mizuno, Tomohiro, Takahiro Hayashi, Rina Kato, et al.. (2014). Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease. Therapeutics and Clinical Risk Management. 10. 73–73. 2 indexed citations
16.
Mizuno, Tomohiro, Takahiro Hayashi, Kazuo Takahashi, et al.. (2014). Efficacy and safety of febuxostat in elderly female patients. Clinical Interventions in Aging. 9. 1489–1489. 7 indexed citations
17.
Ōnishi, Akira, Daisuke Sugiyama, Takashi Nakazawa, et al.. (2012). Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study. Modern Rheumatology. 23(1). 89–96. 9 indexed citations
18.
Sato, Ryuichiro, Masaya Oikawa, Yu Katayose, et al.. (2007). Surgical Resection for Gastric GIST with Multiple Liver Metastases after Imatinib Therapy. The Japanese Journal of Gastroenterological Surgery. 40(4). 427–432. 2 indexed citations
19.
Hayashi, Hiroki, Shinya Wakusawa, & Motoyoshi Yano. (2006). Iron removal by phlebotomy for the prophylaxis of fulminant hepatitis in a Wilson disease model of Long-Evans Cinnamon Rats. Hepatology Research. 35(4). 276–280. 6 indexed citations
20.
Hayashi, Hiroki, et al.. (2001). Body iron stores and iron restoration rate in Japanese patients with chronic hepatitis C as measured during therapeutic iron removal revealed neither increased body iron stores nor effects of C282Y and H63D mutations on iron indices.. PubMed. 64(1-2). 51–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Tinti Breakdown of academic impact, for papers by P Berthoux Breakdown of academic impact, for papers by Jyh-Chang Hwang Breakdown of academic impact, for papers by Leena Ong-Ajyooth Breakdown of academic impact, for papers by Yufeng Qing Breakdown of academic impact, for papers by Jan Bruensing Breakdown of academic impact, for papers by Saima Chohan Breakdown of academic impact, for papers by Pedram Ahmadpoor Breakdown of academic impact, for papers by Chiara Cantarelli Breakdown of academic impact, for papers by Calogero Lino Cirami
Rankless by CCL
2026